Showing results (831-840 of 2,488) with videos related to
Sort By:
Pageof 249
Expert Review of Vaccines|March 8, 2008
Current challenges in the development of vaccines for pneumonic plagueStephen T SmileyExpert Review of Vaccines|March 8, 2008
Pandemic H5N1 influenza vaccine development: an updateHana M El Sahly, Wendy A KeitelExpert Review of Vaccines|February 7, 2008
Challenges of Global Vaccine DevelopmentLindvi Gudmundsdotter, David HallengärdExpert Review of Vaccines|February 7, 2008
Genetically engineered Tobacco mosaic virus as nanoparticle vaccinesAlison A McCormick, Kenneth E PalmerExpert Review of Vaccines|February 7, 2008
Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USACarlos G Grijalva, Marie R GriffinExpert Review of Vaccines|May 1, 2008
Age-related decline in immunity: implications for vaccine responsivenessRajesh Kumar, Edith A BurnsExpert Review of Vaccines|May 1, 2008
New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infectionsLynn G Dover, Apoorva Bhatt, Veemal Bhowruth, et al.Expert Review of Vaccines|April 9, 2008
HIV vaccine research in Thailand: lessons learnedPunnee PitisuttithumExpert Review of Vaccines|January 21, 2025
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variantsGuiqiang Wang, Kexin Zhao, Xiuli Zhao, et al.Expert Review of Vaccines|January 27, 2025
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled studyAlane Izu, Eleanora Aml Mutsaerts, Courtney Olwagen, et al.Pageof 249